Table 1. Summary of risk assessment scientific criteria.
Risk Elements for Likelihood Risk Score | Representative Criteria (examples) |
---|---|
Receptor binding properties | • α2,3-linked sialic acids • α2,3 and α2,6-linked sialic acids • α2,6-linked sialic acids |
Transmission in animal models | • No direct or respiratory droplet • Consistent direct contact • Consistent respiratory droplet |
Genomic characteristics | • No molecular signatures of human infection and disease. • Molecular signatures • Contains genes derived from a virus circulating in mammals |
Infection in animals | • Wild species • Poultry or mammals • Endemicity • Numbers of impacted animals |
Geographic distribution in animals | • Local and contained • Regional within well-defined geographic boundaries. • Widespread no boundaries |
Risk Elements for Impact Risk Score | |
Disease severity (human) | • Uncomplicated • Uncomplicated but some severe illness (underlying conditions) • Severe disease |
Population immunity | • Cross-reactive antibodies > 30% of population except children < 17 • Cross-reactive antibodies > 30% of people >50 • Minimal (<10%) cross-reactive antibodies |
Susceptibility to antiviral treatment | • Resistant to adamantanes • Above + resistant to 1 NA inhibitor • Above + resistant to > 1 NA inhibitor |
Genomic characteristics | As above |
Receptor binding properties | As above |
Human infection | • Single case • Isolated or sporadic cases • Frequent separate clusters |